FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087721 [Registered on: 27/05/2025] Trial Registered Prospectively
Last Modified On: 26/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Usage of Multiple drugs in hypertensive patients. 
Scientific Title of Study   To Study The Prevalence Of Polypharmacy Among Patients With Hypertension At Tertiary Care Hospital In North India 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  AJINK VASUDEV PAWAR 
Designation  Junior resident  
Affiliation  Government medical college and rajindra hospital 
Address  Department of pharmacology, Government medical college Patiala, Sangrur Rd, opposite Rajindra Hospital, New Lal Bagh Colony, Patiala, Punjab.

Patiala
PUNJAB
147001
India 
Phone  08928736224  
Fax    
Email  vasudevpawarajink@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Anjleen kaur  
Designation  Associate professor  
Affiliation  Government medical college and rajindra hospital  
Address  Department of pharmacology, Government medical college Patiala,Sangrur Rd, opposite Rajindra Hospital, New Lal Bagh Colony, Patiala, Punjab.
Patiala Subdistrict
Patiala
PUNJAB
147001
India 
Phone  9855210999  
Fax    
Email  anjleen9@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Anjleen kaur  
Designation  Associate professor  
Affiliation  Government medical college and rajindra hospital  
Address  Department of pharmacology, Government medical college Patiala,Sangrur Rd, opposite Rajindra Hospital, New Lal Bagh Colony, Patiala, Punjab.
Patiala Subdistrict
Patiala
PUNJAB
147001
India 
Phone  9855210999  
Fax    
Email  anjleen9@gmail.com  
 
Source of Monetary or Material Support  
Rajindra Hospital , Patiala Department of pharmacology Government medical College Patiala , Sangrur Rd, opposite Rajindra Hospital, New Lal Bagh Colony, Patiala, Punjab, 147001, India.  
 
Primary Sponsor  
Name  Department of pharmacology Government medical college,Patiala  
Address  Government medical College Patiala,Sangrur Rd, opposite Rajindra Hospital, New Lal Bagh Colony, Patiala, Punjab 147001, India  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ajink Vasudev pawar  Rajindra Hospital  Room no 1A, unit -2, outpatient department of medicine. Patiala PUNJAB
Patiala
PUNJAB 
08928736224

vasudevpawarajink@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee, Government medical college , Patiala   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I119||Hypertensive heart disease withoutheart failure,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Individuals having systolic blood pressure of 140-179mmHg and diastolic blood pressure of 90-109mmHg.

2. Hypertensive patients.

3. Hypertensive patients with co morbid conditions such as diabetes mellitus etc.



 
 
ExclusionCriteria 
Details  1. Patients who did not give informed consent.
2. Patients less than 18 years and more than 80 years old.
3. Patients with severe illness such as chronic kidney disease, malignancy. etc.
4. Pregnant and lactating women. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess the prevalence of Polypharmacy Among hypertensive patients attending out patient department of medicine.  3 months 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="92"
Sample Size from India="92" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Polypharmacy is associated with drug–drug or food–drug interactions that may pose treatment difficulties. The effects of polypharmacy are numerous and should concern physicians and policy makers both in terms of finances (due to significant health costs) and medical consequences (due to multiple drug interactions).The aim of this study is to evaluate the prevalence of polypharmacy among hypertensive patients at tertiary care hospital in North India.

 
Close